Cargando…

Cyclosporine A at Reperfusion Reduces Infarct Size in Pigs

Detalles Bibliográficos
Autores principales:	Skyschally, Andreas, Schulz, Rainer, Heusch, Gerd
Formato:	Texto
Lenguaje:	English
Publicado:	Springer US 2010
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2855028/ https://www.ncbi.nlm.nih.gov/pubmed/20182781 http://dx.doi.org/10.1007/s10557-010-6219-y

Ejemplares similares

Infarct size reduction by cyclosporine A at reperfusion involves inhibition of the mitochondrial permeability transition pore but does not improve mitochondrial respiration
por: Gedik, Nilguen, et al.
Publicado: (2013)

Reduction of Myocardial Infarct Size by Dronedarone in Pigs—A Pleiotropic Action?
por: Skyschally, Andreas, et al.
Publicado: (2011)

Larger infarct size but equal protection by ischemic conditioning in septum and anterior free wall of pigs with LAD occlusion
por: Skyschally, Andreas, et al.
Publicado: (2019)

No robust reduction of infarct size and no-reflow by metoprolol pretreatment in adult Göttingen minipigs
por: Kleinbongard, Petra, et al.
Publicado: (2023)

Diazoxide is a powerful cardioprotectant but is not feasible in a realistic infarct scenario
por: Kleinbongard, Petra, et al.
Publicado: (2023)

Proteomics/phosphoproteomics of left ventricular biopsies from patients with surgical coronary revascularization and pigs with coronary occlusion/reperfusion: remote ischemic preconditioning
por: Gedik, Nilgün, et al.
Publicado: (2017)

Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion
por: Boengler, Kerstin, et al.
Publicado: (2010)

Cardiomyocyte mitochondria as targets of humoral factors released by remote ischemic preconditioning
por: Gedik, Nilguen, et al.
Publicado: (2016)

Cosmetically Disfiguring Side Effects of Cyclosporine
por: Panicker, Vinitha Varghese, et al.
Publicado: (2012)

Cyclosporine Effects on Pediatric Kidney Recipients
por: Hami, Maryam
Publicado: (2012)

Bioequivalence study of cyclosporine in renal transplant recipients
por: Gautam, Gagan
Publicado: (2007)

Effect of Erdosteine on Cyclosporine Induced Chronic Nephrotoxicity
por: Briguori, Carlo, et al.
Publicado: (2012)

Lichen striatus successfully treated with oral cyclosporine
por: Romita, Paolo, et al.
Publicado: (2017)

Monitoring of Cyclosporine A Blood Levels in Clinical Settings
por: Niemczyk, Mariusz
Publicado: (2012)

Cyclosporine has a potential role in the treatment of SARS
por: Russell, Clark D., et al.
Publicado: (2013)

Gingival enlargement due to Cyclosporine A therapy in aplastic anaemia
por: Sabnis, Girish R., et al.
Publicado: (2011)

Insights into the Possible Mechanism of Cyclosporine-Induced Chronic Nephrotoxicity; Arteriolopathy
por: Yoon, Sang Pil
Publicado: (2012)

Still the Joker in the Pack: When to Take Out Cyclosporine in the Game?
por: Resál, Tamás, et al.
Publicado: (2021)

Is the interaction between ticlopidine and cyclosporin dose related? Report of three cases
por: Houssaïni, Tarik Sqalli, et al.
Publicado: (2010)

A Pediatric Patient with Intravenous Cyclosporine Anaphylaxis Who Tolerated the Oral Form
por: Işık, Pamir, et al.
Publicado: (2014)

Cyclosporine-Induced Posterior Reversible Encephalopathy Syndrome in a Patient with Pemphigus Vulgaris
por: Park, So Eun, et al.
Publicado: (2015)

Why choose cyclosporin A as first-line therapy in COVID-19 pneumonia()
por: Sanchez-Pernaute, Olga, et al.
Publicado: (2021)

Why choose cyclosporin A as first-line therapy in COVID-19 pneumonia()
por: Sanchez-Pernaute, Olga, et al.
Publicado: (2021)

Atrioventricular block after reperfusion: A reflection on early beta-blocker therapy for acute myocardial infarction
por: Zhong, Yue, et al.
Publicado: (2017)

A Case of Kaposi's Varicelliform Eruption in a Patient with Psoriasis Receiving Cyclosporine Therapy
por: Külcü Çakmak, Seray, et al.
Publicado: (2015)

Effect of Cyclosporine on Lesion Growth and Infarct Size within the White and Gray Matter
por: Ong, Elodie, et al.
Publicado: (2017)

Translational issues for mitoprotective agents as adjunct to reperfusion therapy in patients with ST‐segment elevation myocardial infarction
por: Bøtker, Hans Erik, et al.
Publicado: (2020)

Non-responsiveness to cardioprotection by ischaemic preconditioning in Ossabaw minipigs with genetic predisposition to, but without the phenotype of the metabolic syndrome
por: Kleinbongard, Petra, et al.
Publicado: (2022)

New Insights on the “DC Shock-Reperfusion” in ST Elevation Myocardial Infarction: Killing Two Birds with One Stone?
por: Özdamar, Ümran, et al.
Publicado: (2017)

Cyclosporine Drug Levels: Comparison of the Architect 1000i with the Siemens Dimension RXL System
por: Chavan, Preeti, et al.
Publicado: (2015)

Veno-occlusive unloading of the heart reduces infarct size in experimental ischemia–reperfusion
por: Hansen, Esben Søvsø Szocska, et al.
Publicado: (2021)

Experimental parameters and infarct size in closed chest pig LAD ischemia reperfusion models; lessons learned
por: Silvis, Max J. M., et al.
Publicado: (2021)

A Case of Cyclosporine-Induced Sebaceous Hyperplasia in a Renal Transplant Patient Successfully Treated with Isotretinoin
por: Jung, Hwa Young, et al.
Publicado: (2016)

Clinical effects of cyclosporine A on reperfusion injury in myocardial infarction: a meta-analysis of randomized controlled trials
por: Yingzhong, Chen, et al.
Publicado: (2016)

Long-term outcome following cyclosporine-related neurotoxicity in paediatric allogeneic haematopoietic stem cell transplantation
por: Straathof, K, et al.
Publicado: (2017)

Selective Inhibition of Succinate Dehydrogenase in Reperfused Myocardium with Intracoronary Malonate Reduces Infarct Size
por: Valls-Lacalle, Laura, et al.
Publicado: (2018)

Toxic epidermal necrolysis in an 8-year-old girl successfully treated with cyclosporin A, intravenous immunoglobulin and plasma exchange
por: Zielińska, Marzena, et al.
Publicado: (2018)

Impact of Morphine Treatment on Infarct Size and Reperfusion Injury in Acute Reperfused ST-Elevation Myocardial Infarction
por: Eitel, Ingo, et al.
Publicado: (2020)

No Association Between Cyclosporine Levels and Dyslipidemia?
por: Filler, Guido
Publicado: (2014)

Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction: trials and tribulations
por: Hausenloy, Derek J., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_r4umvu8g4jb2o6kgoujivij6oc